Still trying to figure out the main advantages of SM6 over some of the other antibody on the market to treat MM - e.g. Daratumumab,Tabalumab, MOR202 etc etc...
Why would Onyx choose SM6 as a potential partner over other antibodies out there or another class of MM Tx?
Can someone please elaborate?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 92467639 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 55715191 | 24 |
View Market Depth
| Last trade - 16.21pm 16/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable